Changzhou SynTheAll Pharmaceutical (WuXi STA)

China

Profile last updated: 2026-10-28

Small Molecule API Peptides & Oligos

Program data pending ClinicalTrials.gov matching

Profiled

Not yet scored

✓ FDA Inspections (2) ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP ✓ HC GMP (13)

Quick Facts: Changzhou SynTheAll Pharmaceutical (WuXi STA)

Signal Score: Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
Headquarters: China
Website: https://wuxiapptec.com/
Modalities: Small Molecule API, Peptides & Oligos
Active Programs: No ClinicalTrials.gov matches confirmed
Data Sources: FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring

About Changzhou SynTheAll Pharmaceutical (WuXi STA)

Changzhou SynTheAll Pharmaceutical (WuXi STA) is a contract development and manufacturing organization (CDMO). Capabilities: Small Molecule API, Peptides & Oligos. 3 manufacturing sites registered with the U.S. FDA and Health Canada. Website: https://wuxiapptec.com/

Signal Score

Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works

Changzhou SynTheAll Pharmaceutical (WuXi STA) FDA Inspection History

2025-04

2025-03

NAI VAI OAI

Date	Site	Type	Observations	Classification
2025-04-25	Shanghai SynTheAll Pharmaceutical Co., Ltd. Jinshan District, Shaanghai Company-level	Drug Quality Assurance	No	Voluntary Action Indicated (VAI)
2025-03-07	Changzhou SynTheAll Pharmaceutical Co., Ltd Changzhou Company-level	Drug Quality Assurance	No	No Action Indicated (NAI)

Source: FDA Data Dashboard · Retrieved Nov 01, 2026

Japan-accredited overseas site (PMDA)

general (non-sterile) · 3 sites

Shanghai, China · Shanghai SynTheAll Pharmaceutical Co., Ltd. — general (non-sterile) · valid to May 22, 2028
Taixing, China · Taixing SynTheAll Pharmaceutical Co., Ltd. — general (non-sterile) · valid to Apr 30, 2030
China · Changzhou SynTheAll Pharmaceutical Co., Ltd — general (non-sterile) · valid to Dec 17, 2029

PMDA accreditation of a foreign manufacturing site is recognition within Japan's regulatory system, not an inspection outcome. PMDA's list covers only manufacturing sites outside Japan, so a company's plants in Japan are not on it. Source: PMDA, list of accredited/registered foreign manufacturers (as of Oct 16, 2026), Public Data License 1.0 (terms)

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this

No hiring data yet. We haven't found a public jobs feed for this company.

Source: public careers pages · Checked Oct 31, 2026

Frequently Asked Questions About Changzhou SynTheAll Pharmaceutical (WuXi STA)

How many FDA inspections does Changzhou SynTheAll Pharmaceutical (WuXi STA) have on record?

CDMO Signal tracks 2 FDA inspections for Changzhou SynTheAll Pharmaceutical (WuXi STA), sourced from the FDA inspection database. See the full inspection history above.

Has Changzhou SynTheAll Pharmaceutical (WuXi STA) received an FDA warning letter?

CDMO Signal has no FDA warning letters on record for Changzhou SynTheAll Pharmaceutical (WuXi STA).

Does Changzhou SynTheAll Pharmaceutical (WuXi STA) have a CDMO Signal Score?

Not yet. Changzhou SynTheAll Pharmaceutical (WuXi STA) is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.

Evaluating Changzhou SynTheAll Pharmaceutical (WuXi STA) for a manufacturing program?

Use the free AI matchmaker to compare Changzhou SynTheAll Pharmaceutical (WuXi STA) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.

Find & compare CDMOs →

Represent this organization? Contact us to verify or update this profile.